Hörig H - Search Results

1

Carcinoembryonic antigen (CEA) presentation and specific T cell-priming by human dendritic cells transfected with CEA-mRNA.

Eppler E, Hörig H, Kaufman HL, Groscurth P, Filgueira L. Eppler E, et al. Among authors: horig h. Eur J Cancer. 2002 Jan;38(1):184-93. doi: 10.1016/s0959-8049(01)00342-2. Eur J Cancer. 2002. PMID: 11750849

2

Prostate-specific antigen vaccines for prostate cancer.

Hörig H, Lee CS, Kaufman HL. Hörig H, et al. Expert Opin Biol Ther. 2002 Apr;2(4):395-408. doi: 10.1517/14712598.2.4.395. Expert Opin Biol Ther. 2002. PMID: 11955277 Review.

3

A new mouse model for evaluating the immunotherapy of human colorectal cancer.

Hörig H, Wainstein A, Long L, Kahn D, Soni S, Marcus A, Edelmann W, Kucherlapati R, Kaufman HL. Hörig H, et al. Cancer Res. 2001 Dec 1;61(23):8520-6. Cancer Res. 2001. PMID: 11731437

4

Strategies for cancer therapy using carcinoembryonic antigen vaccines.

Hörig H, Medina FA, Conkright WA, Kaufman HL. Hörig H, et al. Expert Rev Mol Med. 2000 Apr 19;2(3):1-24. doi: 10.1017/S146239940000168X. Expert Rev Mol Med. 2000. PMID: 14585140

5

Exogenous glutamine requirement is confined to late events of T cell activation.

Hörig H, Spagnoli GC, Filgueira L, Babst R, Gallati H, Harder F, Juretic A, Heberer M. Hörig H, et al. J Cell Biochem. 1993 Dec;53(4):343-51. doi: 10.1002/jcb.240530412. J Cell Biochem. 1993. PMID: 7905486

6

Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule.

Hörig H, Lee DS, Conkright W, Divito J, Hasson H, LaMare M, Rivera A, Park D, Tine J, Guito K, Tsang KW, Schlom J, Kaufman HL. Hörig H, et al. Cancer Immunol Immunother. 2000 Nov;49(9):504-14. doi: 10.1007/s002620000146. Cancer Immunol Immunother. 2000. PMID: 11092617 Free PMC article. Clinical Trial.

7

Immunotherapy for pancreatic cancer: current concepts.

Kaufman HL, Di Vito J Jr, Hörig H. Kaufman HL, et al. Among authors: horig h. Hematol Oncol Clin North Am. 2002 Feb;16(1):159-97, viii. doi: 10.1016/s0889-8588(01)00002-8. Hematol Oncol Clin North Am. 2002. PMID: 12063825 Review.

8

Local delivery of poxvirus vaccines for melanoma.

Hörig H, Kaufman HL. Hörig H, et al. Semin Cancer Biol. 2003 Dec;13(6):417-22. doi: 10.1016/j.semcancer.2003.09.005. Semin Cancer Biol. 2003. PMID: 15001160 Review.

9

Local delivery of recombinant vaccinia virus expressing secondary lymphoid chemokine (SLC) results in a CD4 T-cell dependent antitumor response.

Flanagan K, Glover RT, Hörig H, Yang W, Kaufman HL. Flanagan K, et al. Among authors: horig h. Vaccine. 2004 Jul 29;22(21-22):2894-903. doi: 10.1016/j.vaccine.2003.12.021. Vaccine. 2004. PMID: 15246626

10

Poxviruses as vectors for cancer immunotherapy.

Kwak H, Hörig H, Kaufman HL. Kwak H, et al. Among authors: horig h. Curr Opin Drug Discov Devel. 2003 Mar;6(2):161-8. Curr Opin Drug Discov Devel. 2003. PMID: 12669450 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters